AbbVie Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | $2.25 | $2.26 | $2.25 |
| Q2 2024 | 4 | $2.57 | $2.57 | $2.57 |
| Q3 2024 | 6 | $2.91 | $2.93 | $2.92 |
| Q4 2024 | 15 | $2.94 | $3.08 | $2.97 |
| Q1 2025 | 5 | $2.39 | $2.89 | $2.60 |
| Q2 2025 | 4 | $3.12 | $3.31 | $3.19 |
| Q3 2025 | 4 | $3.12 | $3.31 | $3.19 |
| Q4 2025 | 4 | $3.19 | $3.38 | $3.26 |
| Q1 2026 | 3 | $2.57 | $2.72 | $2.62 |
| Q2 2026 | 3 | $3.56 | $3.77 | $3.64 |
| Q3 2026 | 3 | $3.23 | $3.42 | $3.30 |
| Q4 2026 | 3 | $3.50 | $3.70 | $3.57 |
| Q1 2027 | 3 | $2.78 | $2.95 | $2.85 |
| Q2 2027 | 3 | $3.87 | $4.10 | $3.95 |
| Q3 2027 | 3 | $3.53 | $3.74 | $3.61 |
| Q4 2027 | 3 | $3.80 | $4.03 | $3.88 |
AbbVie Inc. Earnings Date And Information
AbbVie Inc. last posted its earnings results on Wednesday, October 30th, 2024. The company reported $3 earnings per share for the quarter, topping analysts' consensus estimates of $2.92 by $0.08. The company had revenue of 14.46 B for the quarter and had revenue of 54.32 B for the year. AbbVie Inc. has generated $3 earnings per share over the last year ($2.72 diluted earnings per share) and currently has a price-to-earnings ratio of 61.11. AbbVie Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 31st, 2025 based on prior year's report dates.
AbbVie Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/04/2024 | Q3 2024 | $0.88 | $14.28 B | $14.46 B | ||
| 08/07/2024 | Q2 2024 | $0.78 | $14.02 B | $14.46 B | ||
| 05/03/2024 | Q1 2024 | $0.77 | $12.31 B | |||
| 02/20/2024 | Q4 2023 | $0.46 | $14.30 B | |||
| 11/06/2023 | Q3 2023 | $1.00 | $13.72 B | $13.93 B | ||
| 08/07/2023 | Q2 2023 | $1.14 | $13.54 B | $13.87 B | ||
| 05/05/2023 | Q1 2023 | $0.13 | $12.23 B | |||
| 02/17/2023 | Q4 2022 | $1.40 | $15.12 B | |||
| 11/04/2022 | Q3 2022 | $2.23 | $14.96 B | $14.81 B | ||
| 08/04/2022 | Q2 2022 | $0.52 | $14.66 B | $14.58 B | ||
| 05/06/2022 | Q1 2022 | $2.54 | $13.54 B | |||
| 02/18/2022 | Q4 2021 | $2.29 | $14.89 B | |||
| 11/02/2021 | Q3 2021 | $1.78 | $14.30 B | $14.34 B | ||
| 08/02/2021 | Q2 2021 | $0.42 | $13.63 B | $13.96 B | ||
| 05/07/2021 | Q1 2021 | $2.00 | $13.01 B | |||
| 02/19/2021 | Q4 2020 | $0.02 | $13.86 B | |||
| 11/04/2020 | Q3 2020 | $1.30 | $12.72 B | $12.90 B | ||
| 08/04/2020 | Q2 2020 | -$0.45 | $9.94 B | $10.43 B | ||
| 05/07/2020 | Q1 2020 | $2.02 | $8.62 B | |||
| 02/21/2020 | Q4 2019 | $1.89 | $8.70 B |
AbbVie Inc. Earnings: Frequently Asked Questions
-
When is AbbVie Inc.'s earnings date?
AbbVie Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, January 31st, 2025 based off last year's report dates.
-
Did AbbVie Inc. beat their earnings estimates last quarter?
In the previous quarter, AbbVie Inc. (:ABBV) reported $3 earnings per share (EPS) to beat the analysts' consensus estimate of $2.92 by $0.08.
-
How can I listen to AbbVie Inc.'s earnings conference call?
The conference call for AbbVie Inc.'s latest earnings report can be listened to online.
-
How can I read AbbVie Inc.'s conference call transcript?
The conference call transcript for AbbVie Inc.'s latest earnings report can be read online.
-
How much revenue does AbbVie Inc. generate each year?
AbbVie Inc. (:ABBV) has a recorded annual revenue of $54.32 B.
-
How much profit does AbbVie Inc. generate each year?
AbbVie Inc. (:ABBV) has a recorded net income of $54.32 B. AbbVie Inc. has generated $2.73 earnings per share over the last four quarters.
-
What is AbbVie Inc.'s price-to-earnings ratio?
AbbVie Inc. (:ABBV) has a price-to-earnings ratio of 61.11 and price/earnings-to-growth ratio is -1.84.
